Breaking News Instant updates and real-time market news.

AMRB

American River

$13.75

0.5 (3.77%)

, AX

Axos Financial

$32.75

0.58 (1.80%)

04:55
03/06/19
03/06
04:55
03/06/19
04:55

Sandler O'Neill to hold a conference

2019 West Coast Financial Services Conference will be held in San Diego, CA on March 4-6.

AMRB

American River

$13.75

0.5 (3.77%)

AX

Axos Financial

$32.75

0.58 (1.80%)

BANR

Banner Corp.

$60.40

-0.71 (-1.16%)

BOH

Bank of Hawaii

$82.99

0.36 (0.44%)

CADE

Cadence Bancorp

$20.10

0.07 (0.35%)

CBTX

CBTX

$33.61

0.15 (0.45%)

CCFN

CCFNB Bancorp

$0.00

(0.00%)

CHFC

Chemical Financial

$45.43

-0.45 (-0.98%)

COLB

Columbia Banking

$37.69

-0.09 (-0.24%)

CPF

Central Pacific

$29.58

0.17 (0.58%)

HAFC

Hanmi Financial

$22.80

-0.06 (-0.26%)

GNTY

Guaranty Bancshares

$30.56

-0.01 (-0.03%)

MYFW

First Western Financial

$13.55

(0.00%)

LBC

Luther Burbank

$10.41

0.11 (1.07%)

HTH

Hilltop Holdings

$18.90

-0.32 (-1.66%)

PPBI

Pacific Premier

$29.33

-0.22 (-0.74%)

PROV

Provident Financial

$20.06

-0.08 (-0.40%)

RBB

RBB Bancorp

$21.98

-0.13 (-0.59%)

HOPE

Hope Bancorp

$14.63

0.1 (0.69%)

HTBK

Heritage Commerce

$13.73

-0.06 (-0.44%)

PCB

Pacific City Financial

$17.48

-0.11 (-0.63%)

OPB

Opus Bank

$22.81

0.005 (0.02%)

NRIM

Northrim BanCorp

$38.04

-0.01 (-0.03%)

WAL

Western Alliance

$46.32

0.04 (0.09%)

WFC

Wells Fargo

$49.89

-0.23 (-0.46%)

  • 06

    Mar

  • 12

    Mar

  • 01

    May

  • 21

    May

  • 22

    May

  • 28

    May

  • 13

    Jul

  • 12

    Oct

AMRB American River
$13.75

0.5 (3.77%)

10/22/18
RAJA
10/22/18
UPGRADE
RAJA
Market Perform
American River upgraded to Market Perform from Underperform at Raymond James
10/22/18
RAJA
10/22/18
UPGRADE
RAJA
Market Perform
American River upgraded to Market Perform, valuation fair, says Raymond James
As previously reported, Raymond James upgraded American River to Market Perform from Underperform. Analyst Donald Worthington said the company has finally begun to produce significant net loan growth combined with net interest margin expansion and views shares as fairly valued.
03/29/18
FIGP
03/29/18
UPGRADE
FIGP
Outperform
American River upgraded to Outperform from Market Perform at Fig Partners
AX Axos Financial
$32.75

0.58 (1.80%)

01/30/19
CHLM
01/30/19
NO CHANGE
Target $40
CHLM
Buy
Axos Financial price target lowered to $40 from $51 at Craig-Hallum
Craig-Hallum analyst Bradley Berning lowered his price target for Axos Financial to $40 from $51 for yield curve environment. The analyst reiterates a Buy rating on the shares.
02/06/19
COMP
02/06/19
UPGRADE
COMP
Buy
Axos Financial upgraded to Buy from Neutral at Compass Point
10/25/18
DADA
10/25/18
NO CHANGE
Target $40
DADA
Buy
Axos Financial price target lowered to $40 from $47 at DA Davidson
DA Davidson analyst Gary Tenner lowered his price target on Axos Financial to $40 after its Q1 results, saying that while the company started FY19 with a "solid quarter" of 10% loan growth and net interest margins within expectations, he is concerned with the outlook for its net interest income. The analyst keeps his Buy rating on Axos Financial to reflect the positive cost impact from its strategic partnerships but lowers his FY19 EPS view to $2.83 from $3.15 and his FY20 view to $3.33 from $3.73.
10/03/18
RAJA
10/03/18
UPGRADE
Target $46
RAJA
Strong Buy
Axos Financial upgraded to Strong Buy at Raymond James
As previously reported, Raymond James upgraded Axos Financial (AX) to Strong Buy from Outperform and a $46 price target. Analyst Donald Worthington said the acquisition of Cor Clearing provides Axos with entry into the securities clearing and brokerage services business and is attractive both strategically and financially.
BANR Banner Corp.
$60.40

-0.71 (-1.16%)

10/26/18
FIGP
10/26/18
UPGRADE
FIGP
Outperform
Banner Corp. upgraded to Outperform from Market Perform at Fig Partners
BOH Bank of Hawaii
$82.99

0.36 (0.44%)

CADE Cadence Bancorp
$20.10

0.07 (0.35%)

12/13/18
BARD
12/13/18
NO CHANGE
Target $28
BARD
Outperform
Cadence Bancorp price target cut to $28 from $32 at Baird
Baird analyst Bryce Rowe maintained an Outperform rating on Cade Bancorp (CADE) and cut his price target to $28 from $32, telling investors in a research note that Cadence is his top idea. Rowe says regional banks have underperformed the broader markets since early summer and that he believes there is ~15%-20% absolute upside available in small-cap bank stocks if a risk-on trade reemerges and that small-cap bank stocks can outperform on a relative basis should broader market weakness persist. The analyst also upgraded Union Bankshares (UBSH) this morning to Outperform.
01/04/19
RHCO
01/04/19
NO CHANGE
Target $18
RHCO
Cadence Bancorp price target lowered to $18 from $24 at SunTrust
SunTrust analyst Jennifer Demba lowered her price target on Cadence Bancorp (CADE) to $18 and kept her Hold rating after the completed State Bank Financial acquisition (STBZ) on January 2nd. The analyst also attributes the price target revision to lower industry valuation levels, adding that the discount on the shares is appropriate based on its lower loan and deposit mix. Demba notes that the bank trades at 7.3-times forward earnings vs. the regional bank per median of 9.7-times.
03/05/19
GSCO
03/05/19
INITIATION
Target $23
GSCO
Buy
Cadence Bancorp reinstated with a Buy at Goldman Sachs
Goldman Sachs analyst Ryan Nash reinstated coverage on Cadence Bancorp with a Buy and $23 price target saying it remains an attractive compounder of book value and believes executing on its strategy will drive shares.
11/08/18
KBWI
11/08/18
UPGRADE
Target $37
KBWI
Outperform
State Bank upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brady Gailey upgraded State Bank Financial (STBZ) to Outperform while lowering his price target for the shares to $37 from $39.50. The analyst is syncing the company's rating with Cadence Bancorp (CADE), a stock he upgraded tonight to Outperform.
CBTX CBTX
$33.61

0.15 (0.45%)

CCFN CCFNB Bancorp
$0.00

(0.00%)

CHFC Chemical Financial
$45.43

-0.45 (-0.98%)

02/08/19
SDLR
02/08/19
UPGRADE
SDLR
Buy
Chemical Financial, TCF Financial upgraded to Buy at Sandler O'Neill
As previously reported, Sandler O'Neill analyst R. Scott Siefers upgraded Chemical Financial (CHFC) and TCF Financial (TCF), both to Buy from Hold, after sitting down with senior management from both to discuss their pending merger of equals. At the time of the deal announcement, he was still a bit concerned about a potential repeat of the post-close dislocation that has overshadowed the Chemical/Talmer deal, said Siefers, who noted that his conversations with management have served to build his confidence in the merger's likely success, even "beyond the up-front compelling financials." He raised his price target on Chemical Financial shares to $54 from $49 and increased his price target on TCF Financial to $27.45 from $24.90.
02/08/19
SDLR
02/08/19
UPGRADE
SDLR
Buy
Chemical Financial upgraded to Buy from Hold at Sandler O'Neill
01/29/19
01/29/19
DOWNGRADE
Target $24.9

Hold
Sandler O'Neill downgrades TCF Financial to Hold after Chemical Financial deal
As previously reported, Sandler O'Neill analyst R. Scott Siefers downgraded TCF Financial (TCF) to Hold from Buy to align his rating with Chemical Financial (CHFC) after the two announced a merger of equals. He raised his price target on TCF Financial shares to $24.90 from $24.00 as he applied the exchange ratio outlined in the terms of the merger agreement to his Chemical Financial price target.
01/29/19
BMOC
01/29/19
UPGRADE
Target $29
BMOC
Outperform
TCF Financial upgraded to Outperform from Market Perform at BMO Capital
BMO Capital analyst Lana Chan upgraded TCF Financial (TCF) to Outperform and raised her price target to $29 from $22 while also raising her FY20 EPS view by 19% to $2.50. The analyst believes that the deal for Chemical Financial (CHFC) is "well structured" and "positive for both sets of shareholders". She also sees the earnings accretion from the transaction as attractive and the dilution earn-back period as reasonable.
COLB Columbia Banking
$37.69

-0.09 (-0.24%)

11/08/18
KBWI
11/08/18
UPGRADE
Target $45
KBWI
Outperform
Columbia Banking upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Jacquelynne Bohlen upgraded Columbia Banking to Outperform with a $45 price target saying the company will benefit from a "strong" deposit profile.
11/12/18
SDLR
11/12/18
UPGRADE
SDLR
Buy
Columbia Banking upgraded to Buy from Hold at Sandler ONeill
CPF Central Pacific
$29.58

0.17 (0.58%)

HAFC Hanmi Financial
$22.80

-0.06 (-0.26%)

10/24/18
FIGP
10/24/18
DOWNGRADE
FIGP
Market Perform
Hanmi Financial downgraded to Market Perform from Outperform at Fig Partners
01/07/19
RAJA
01/07/19
DOWNGRADE
RAJA
Market Perform
Hanmi Financial downgraded to Market Perform from Outperform at Raymond James
GNTY Guaranty Bancshares
$30.56

-0.01 (-0.03%)

12/19/18
SPHN
12/19/18
UPGRADE
Target $34
SPHN
Overweight
Guaranty Bancshares upgraded to Overweight from Equal Weight at Stephens
Stephens analyst Matt Olney upgraded Guaranty Bancshares (GNTY) to Overweight from Equal Weight as he believes the bank to be among a group of Southwest banking peers that offer attractive positioning in line with a more defensive sentiment. Regional credit trends remain excellent in the Southwest region, noted Olney, who expects Guaranty to make steady progress towards its 1.20% ROA goal by late 2019. He raised his price target on Guaranty shares to $34 from $31. He also upgraded peers UMB Financial (UMBF) and Iberiabank (IBKC) this morning.
12/19/18
SPHN
12/19/18
UPGRADE
Target $75
SPHN
Overweight
UMB Financial upgraded to Overweight from Equal Weight at Stephens
Stephens analyst Matt Olney upgraded UMB Financial (UMBF) to Overweight from Equal Weight as he believes the bank to be among a group of Southwest banking peers that offer attractive positioning in line with a more defensive sentiment. Regional credit trends remain excellent in the Southwest region, noted Olney, who adds that he feels UMB's consensus EPS forecasts are "reasonable with limited downside." He raised his price target on UMB Financial shares to $75 from $70. He also upgraded peers Iberiabank (IBKC) and Guaranty Bancshares (GNTY) this morning.
MYFW First Western Financial
$13.55

(0.00%)

08/13/18
KBWI
08/13/18
INITIATION
Target $24
KBWI
Outperform
First Western Financial initiated with an Outperform at Keefe Bruyette
Keefe Bruyette analyst Michael Belmes started First Western Financial with an Outperform rating and $24 price target. The bank has the capital needed to continue to grow its franchise and realize "substantial" operating leverage and profitability improvement, Belmes tells investors in a research note.
10/29/18
SPHN
10/29/18
DOWNGRADE
Target $16
SPHN
Equal Weight
First Western Financial downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Matt Olney downgraded First Western Financial to Equal Weight and lowered his price target for the shares to $16 from $21. The company's first results post the initial public offering were disappointing as revenue headwinds were evident in loan growth, fees and net interest margin, Olney tells investors in a research note. The analyst now assumes more gradual efficiency improvements in 2019 and says the company's earnings ramp is now "pushed out."
LBC Luther Burbank
$10.41

0.11 (1.07%)

HTH Hilltop Holdings
$18.90

-0.32 (-1.66%)

10/29/18
RAJA
10/29/18
UPGRADE
RAJA
Market Perform
Hilltop Holdings upgraded to Market Perform from Underperform at Raymond James
09/25/18
SPHN
09/25/18
NO CHANGE
SPHN
FB Financial guidance may add caution about mortgage heavy banks, says Stephens
Stephens analyst Tyler Stafford noted that FB Financial (FBK) has lowered its mortgage expectations for the second half of the year, which he sees being driven by softer volumes than originally expected coupled with incremental GOS margin pressure. Stafford thinks FB Financial's guidance may make investors incrementally more cautious around other mortgage heavy banks, he tells investors. On a list of banks with the largest GOS mortgage exposures as a percentage of revenue as of Q2 2018, Stafford identifies HomeStreet (HMST), Hilltop Holdings (HTH), Fidelity Southern (LION) and Flagstar Bancorp (FBC) alongside FB Financial.
07/31/18
COMP
07/31/18
UPGRADE
COMP
Buy
Hilltop Holdings upgraded to Buy from Neutral at Compass Point
Compass Point analyst Chris Gamaitoni upgraded Hilltop Holdings to Buy with a $25 price target saying valuation reflects mortgage pressures.
05/14/18
COMP
05/14/18
DOWNGRADE
COMP
Neutral
Hilltop Holdings downgraded to Neutral from Buy at Compass Point
PPBI Pacific Premier
$29.33

-0.22 (-0.74%)

PROV Provident Financial
$20.06

-0.08 (-0.40%)

02/05/19
FIGP
02/05/19
UPGRADE
FIGP
Outperform
Provident Financial upgraded to Outperform from Market Perform at Fig Partners
RBB RBB Bancorp
$21.98

-0.13 (-0.59%)

HOPE Hope Bancorp
$14.63

0.1 (0.69%)

05/30/18
DADA
05/30/18
DOWNGRADE
Target $20
DADA
Neutral
Hope Bancorp downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Gary Tenner downgraded Hope Bancorp to Neutral from Buy and kept his $20 price target, saying that while the company has posted "solid profitability metrics", its 100% loan/deposit ratio will make it challenging to fund growth without hurting net interest margins. The analyst also attributes the rating change to valuation following a run-up in the stock price since the late-April sell-off.
05/30/18
05/30/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Hold from Buy at Maxim with analyst Nehal Chokshi saying he sees high risk that FY19 will be a "down year" given declines in the broader smartphone market. 2. AK Steel (AKS) downgraded to Sell from Neutral at Goldman Sachs with analyst Matthew Korn citing continued underperformance by the company in terms of pricing and margins and also points to its limited visibility around downstream operations. 3. AbbVie (ABBV) downgraded to Underperform from Neutral at Credit Suisse with analyst Vamil Divan saying he is increasingly concerned about the longevity of its flagship product Humira. 4. Petrobras (PBR) downgraded to Hold from Buy at Santander. 5. Hope Bancorp (HOPE) downgraded to Neutral from Buy at DA Davidson with analyst Gary Tenner saying that while the company has posted "solid profitability metrics," its 100% loan/deposit ratio will make it challenging to fund growth without hurting net interest margins. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/18/18
DADA
10/18/18
NO CHANGE
Target $16
DADA
Neutral
Hope Bancorp price target lowered to $16 from $19 at DA Davidson
DA Davidson analyst Gary Tenner lowered his price target on Hope Bancorp to $16 and kept his Neutral rating after its Q3 earnings came in just shy of his estimate. The analyst notes that net interest margin compression has worsened, with the outlook for more softness to come over the intermediate term. Tenner adds that the bank's earnings outlook is dependent on its ability to generate incremental deposits at lower costs, and while there are initiatives to do so, he sees investor concerns regarding its funding costs and net interest margins containing the upside on the shares.
HTBK Heritage Commerce
$13.73

-0.06 (-0.44%)

07/18/18
RAJA
07/18/18
INITIATION
Target $19
RAJA
Outperform
Heritage Commerce initiated with an Outperform at Raymond James
Raymond James analyst Donald Worthington initiated Heritage Commerce with an Outperform and $19 price target. The analyst said Heritage is developing a strong San Francisco Bay area franchise with solid loan and deposit growth, and is well positioned for the future
03/13/18
KBWI
03/13/18
UPGRADE
KBWI
Outperform
Heritage Commerce upgraded to Outperform from Market Perform at Keefe Bruyette
03/13/18
KBWI
03/13/18
UPGRADE
Target $19
KBWI
Outperform
Heritage Commerce upgraded to Outperform with $19 target at Keefe Bruyette
Keefe Bruye analyst Jacquelynne Bohlen upgraded Heritage Commerce to Outperform and raised her price target for the shares to $19 from $18. The analyst expects the company's profitability, deposits and earnings growth to support higher valuation levels.
07/30/18
BMUR
07/30/18
NO CHANGE
Target $19
BMUR
Buy
Heritage Commerce balance sheet position favored at Brean Capital
Brean Capital analyst Blair Brantley tweaked his estimates on Heritage Commerce due to a lower pro forma earnings asset base, but he continues to favor its balance sheet position with strong non-interest bearing deposit balances, elevated asset sensitivity, and its enhanced value position, which he believes is deserving of a fuller valuation. Brantley reiterated his Buy rating and $18.50 price target on Heritage Commerce shares.
PCB Pacific City Financial
$17.48

-0.11 (-0.63%)

09/04/18
KBWI
09/04/18
INITIATION
KBWI
Market Perform
Pacific City Financial initiated with a Market Perform at Keefe Bruyette
Keefe Bruyette analyst Jacquelynne Bohlen started Pacific City Financial with a Market Perform rating and $22 price target. The analyst expects liquidity deployment and balance sheet growth to drive the company's earnings.
09/05/18
SDLR
09/05/18
INITIATION
SDLR
Buy
Pacific City Financial initiated with a Buy at Sandler O'Neill
Sandler O'Neill analyst Aaron James initiated Pacific City Financial with a Buy rating.
09/05/18
09/05/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Universal Display (OLED) initiated with a Buy at Citi. 2. Bio-Rad (BIO) initiated with an Equal Weight at Barclays. 3. Amalgamated Bank (AMAL) initiated with an Overweight at Barclays. 4. Pacific City Financial (PCB) initiated with a Buy at Sandler O'Neill. 5. Nasdaq (NDAQ) initiated with a Neutral at Rosenblatt. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/04/18
RAJA
09/04/18
INITIATION
RAJA
Outperform
Pacific City Financial initiated with an Outperform at Raymond James
Raymond James analyst Donald Worthington initiated Pacific City Financial with an Outperform and $22 price target saying it has generated strong loan and deposit growth, and above average profitability metrics.
OPB Opus Bank
$22.81

0.005 (0.02%)

07/23/18
FIGP
07/23/18
DOWNGRADE
FIGP
Market Perform
Opus Bank downgraded to Market Perform from Outperform at Fig Partners
NRIM Northrim BanCorp
$38.04

-0.01 (-0.03%)

WAL Western Alliance
$46.32

0.04 (0.09%)

01/15/19
SBSH
01/15/19
UPGRADE
Target $53
SBSH
Buy
Western Alliance upgraded to Buy from Neutral at Citi
Citi analyst Arren Cyganovich upgraded Western Alliance Bancorp to Buy while lowering his price target for the shares to $53 from $56.
10/21/18
KBWI
10/21/18
NO CHANGE
Target $75
KBWI
Outperform
Western Alliance should be bought on 'misguided' selloff, says Keefe Bruyette
Keefe Bruyette analyst Christopher McGratty says Friday's 8% selloff in shares of Western Alliance Bancorporation was "misguided." The pullback related to a "misunderstanding" of the company's outlook, which effectively "blessed" 2019 consensus estimates, McGratty tells investors in a research note. He recommends adding to positions in Western Alliance, noting that his estimates are unchanged and the stock is now trading at "just" 11 times his 2019 numbers. The analyst keeps an Outperform rating on the shares with a $75 price target.
10/22/18
RBCM
10/22/18
NO CHANGE
Target $61
RBCM
Outperform
Western Alliance price target lowered to $61 from $68 at RBC Capital
RBC Capital analyst Jon Arfstrom lowered his price target on Western Alliance to $61 to reflect the "recent change in peer multiples" but also kept his Outperform rating following a "solid" set of results in Q3. The analyst notes that while the management was somewhat cautious in terms of its 2019 growth and margins expectations, the outlook was still "strong". Arfstrom added that he "appreciates" Western Alliance's continued "ability to produce above peer growth and returns" along with its strong credit quality.
10/23/18
RHCO
10/23/18
NO CHANGE
Target $63
RHCO
Buy
Western Alliance price target lowered to $63 from $70 at SunTrust
SunTrust analyst Michael Young lowered his price target on Western Alliance to $63 to reflect the contraction in industry multiples but also keeps his Buy rating after the bank's Q3 results. The analyst notes that Western Alliance posted better net interest income growth than its peers thanks to a lower loan to deposit ratio and expects its net interest margins to remain supported.
WFC Wells Fargo
$49.89

-0.23 (-0.46%)

01/02/19
RBCM
01/02/19
UPGRADE
RBCM
Sector Perform
Wells Fargo upgraded to Sector Perform from Underperform at RBC Capital
01/08/19
WOLF
01/08/19
DOWNGRADE
WOLF
Peer Perform
Wells Fargo downgraded to Peer Perform from Outperform at Wolfe Research
01/02/19
RBCM
01/02/19
UPGRADE
Target $48
RBCM
Sector Perform
Wells Fargo upgraded to Sector Perform from Underperform at RBC Capital
As noted earlier, RBC Capital analyst Gerard Cassidy upgraded Wells Fargo to Sector Perform but lowered his price target to $48 from $50. The analyst notes that his prior downgrade was related to expectations that the Federal Reserve's Cease & Desist Order would "seriously hamper" the bank's ability to operate in an "otherwise healthy banking environment." At current prices however, Cassidy contends that the stock "fully discounts" the bank's regulatory risks, also raising his Q4 earnings estimate by 8c to $1.28.
01/07/19
GSCO
01/07/19
DOWNGRADE
Target $144
GSCO
Neutral
PNC Financial downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Richard Ramsden downgraded PNC Financial (PNC) to Neutral and lowered his price target for the shares to $144 from $154. Commercial loan growth has fallen 7 percentage points and is likely to track industry growth rates more closely from here, Ramsden tells investors in a research note. Further, he thinks higher deposit betas could "hinder" PNC's net interest income growth and that the current valuation "appears fair on a relative basis." In an environment where the revenue outlook is uncertain, Bank of America (BAC) and Wells Fargo look best positioned, says Ramsden.

TODAY'S FREE FLY STORIES

FTSV

Forty Seven

$10.55

-0.02 (-0.19%)

13:16
06/16/19
06/16
13:16
06/16/19
13:16
Hot Stocks
Forty Seven announces data from Phase 1b/2 trial of 5F9 in combo with Rituximab »

Forty Seven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

13:06
06/16/19
06/16
13:06
06/16/19
13:06
Hot Stocks
AstraZeneca announces results from interim analysis of Phase 2 ASCEND trial »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

STRO

Sutro Biopharma

$11.17

-0.34 (-2.95%)

13:02
06/16/19
06/16
13:02
06/16/19
13:02
Hot Stocks
Sutro Biopharma announces interim Phase 1 safety data for STRO-001 »

Sutro Biopharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$90.65

-0.35 (-0.38%)

12:59
06/16/19
06/16
12:59
06/16/19
12:59
Hot Stocks
Blueprint Medicines presents updated EXPLORER trial data for Avapritinib »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

INCY

Incyte

$77.76

1.385 (1.81%)

12:52
06/16/19
06/16
12:52
06/16/19
12:52
Hot Stocks
Incyte announced results from Phase 2 study of Ruxolitinib cream in vitiligo »

Incyte announces 24-week…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, INCY

Incyte

$77.76

1.385 (1.81%)

04:55
06/16/19
06/16
04:55
06/16/19
04:55
Conference/Events
European Hematology Association to hold a conference »

24th EHA Congress 2019…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

INCY

Incyte

$77.76

1.385 (1.81%)

ARQL

ArQule

$8.17

1.88 (29.89%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

ALXN

Alexion

$117.94

0.65 (0.55%)

AGIO

Agios Pharmaceuticals

$47.97

-1.78 (-3.58%)

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

BLUE

Bluebird Bio

$117.57

-6.33 (-5.11%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

NSTG

NanoString

$25.96

0.45 (1.76%)

KPTI

Karyopharm

$5.71

-0.04 (-0.70%)

JAZZ

Jazz Pharmaceuticals

$130.43

0.28 (0.22%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PTLA

Portola Pharmaceuticals

$25.78

-0.31 (-1.19%)

QGEN

Qiagen

$39.52

-0.07 (-0.18%)

RHHBY

Roche

$0.00

(0.00%)

RIGL

Rigel Pharmaceuticals

$2.06

-0.06 (-2.83%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

SGEN

Seattle Genetics

$68.67

-0.33 (-0.48%)

STML

Stemline

$14.20

0.12 (0.85%)

VSTM

Verastem

$1.39

0.125 (9.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 25

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

, GRUB

GrubHub

$70.15

-2.76 (-3.79%)

13:28
06/15/19
06/15
13:28
06/15/19
13:28
Periodicals
Amazon exit gives GrubHub stock boost, Barron's says »

Amazon (AMZN) is…

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

, CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

13:20
06/15/19
06/15
13:20
06/15/19
13:20
Periodicals
McKesson, Cardinal Health looking like bargains, Barron's says »

Investors have halved the…

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

MCK

McKesson

$133.19

-1.7 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

RTN

Raytheon

$177.38

0.195 (0.11%)

, UTX

United Technologies

$125.30

0.45 (0.36%)

13:09
06/15/19
06/15
13:09
06/15/19
13:09
Periodicals
United Technologies, Raytheon stocks looking cheap, Barron's says »

Shares of United…

RTN

Raytheon

$177.38

0.195 (0.11%)

UTX

United Technologies

$125.30

0.45 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

, AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

13:04
06/15/19
06/15
13:04
06/15/19
13:04
Periodicals
Food fight extending well beyond restaurant delivery, Barron's says »

Amazon (AMZN) is quitting…

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

GOOGL

Alphabet Class A

$1,086.36

-4.65 (-0.43%)

, GOOG

Alphabet

$1,085.56

-3.52 (-0.32%)

12:59
06/15/19
06/15
12:59
06/15/19
12:59
Periodicals
Facebook, JPMorgan chiefs among Best CEOs of 2019, Barron's says »

Separated into three…

GOOGL

Alphabet Class A

$1,086.36

-4.65 (-0.43%)

GOOG

Alphabet

$1,085.56

-3.52 (-0.32%)

FB

Facebook

$181.35

3.88 (2.19%)

MCD

McDonald's

$205.33

0.85 (0.42%)

JPM

JPMorgan

$109.84

0.26 (0.24%)

BAC

Bank of America

$28.03

0.09 (0.32%)

BLK

BlackRock

$446.96

-1.29 (-0.29%)

BX

Blackstone

$44.13

0.17 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 09

    Jul

  • 10

    Jul

  • 16

    Jul

  • 17

    Jul

  • 06

    Aug

  • 27

    Oct

AVGO

Broadcom

$265.99

-15.96 (-5.66%)

, AAPL

Apple

$192.84

-1.93 (-0.99%)

07:17
06/15/19
06/15
07:17
06/15/19
07:17
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AVGO

Broadcom

$265.99

-15.96 (-5.66%)

AAPL

Apple

$192.84

-1.93 (-0.99%)

HNHPF

Hon Hai Precision

$0.00

(0.00%)

UTX

United Technologies

$125.30

0.45 (0.36%)

RTN

Raytheon

$177.38

0.195 (0.11%)

CGC

Canopy Growth

$41.15

-0.64 (-1.53%)

TLRY

Tilray

$38.96

-1.78 (-4.37%)

APHA

Aphria

$6.80

-0.15 (-2.16%)

ACB

Aurora Cannabis

$7.56

(0.00%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

CRON

Cronos Group

$15.43

-0.92 (-5.63%)

CANN

General Cannabis

$0.00

(0.00%)

IGC

India Globalization Capital

$1.28

0.4201 (48.85%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

ZYNE

Zynerba

$13.03

-0.54 (-3.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

  • 18

    Jun

  • 19

    Jun

  • 21

    Jun

  • 25

    Jun

  • 09

    Jul

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, ABMD

Abiomed

$250.96

-4.58 (-1.79%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
International League of Dermatological Societies to hold a conference »

24th World Congress of…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

ABMD

Abiomed

$250.96

-4.58 (-1.79%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

LLY

Eli Lilly

$111.74

-0.06 (-0.05%)

JNJ

Johnson & Johnson

$140.08

-0.63 (-0.45%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PG

Procter & Gamble

$111.20

0.28 (0.25%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

UL

Unilever; also tag UN

$62.61

-0.07 (-0.11%)

UN

Unilever; also tag UL

$61.30

-0.13 (-0.21%)

INCY

Incyte

$77.76

1.385 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 26

    Jun

  • 27

    Jun

  • 16

    Jul

  • 25

    Jul

  • 30

    Jul

  • 28

    Aug

  • 03

    Sep

  • 16

    Sep

  • 13

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

, GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
European Congress of Rheumatology to hold a conference »

EULAR 2019 will be held…

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

PFE

Pfizer

$42.75

0.24 (0.56%)

LLY

Eli Lilly

$111.74

-0.06 (-0.05%)

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

RHHBY

Roche

$0.00

(0.00%)

BIIB

Biogen

$227.67

-3.57 (-1.54%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

REGN

Regeneron

$305.19

-2.235 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 25

    Jul

  • 30

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, INCY

Incyte

$77.76

1.385 (1.81%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
European Hematology Association to hold a conference »

24th EHA Congress 2019…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

INCY

Incyte

$77.76

1.385 (1.81%)

ARQL

ArQule

$8.17

1.88 (29.89%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

ALXN

Alexion

$117.94

0.65 (0.55%)

AGIO

Agios Pharmaceuticals

$47.97

-1.78 (-3.58%)

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

BLUE

Bluebird Bio

$117.57

-6.33 (-5.11%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

NSTG

NanoString

$25.96

0.45 (1.76%)

KPTI

Karyopharm

$5.71

-0.04 (-0.70%)

JAZZ

Jazz Pharmaceuticals

$130.43

0.28 (0.22%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PTLA

Portola Pharmaceuticals

$25.78

-0.31 (-1.19%)

QGEN

Qiagen

$39.52

-0.07 (-0.18%)

RHHBY

Roche

$0.00

(0.00%)

RIGL

Rigel Pharmaceuticals

$2.06

-0.06 (-2.83%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

SGEN

Seattle Genetics

$68.67

-0.33 (-0.48%)

STML

Stemline

$14.20

0.12 (0.85%)

VSTM

Verastem

$1.39

0.125 (9.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jun

  • 17

    Jun

  • 18

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 25

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

ABT

Abbott

$82.25

-0.03 (-0.04%)

, AMGN

Amgen

$176.09

-0.74 (-0.42%)

04:55
06/15/19
06/15
04:55
06/15/19
04:55
Conference/Events
Society for Vascular Surgery to hold annual meeting »

SVS Annual Meeting 2019…

ABT

Abbott

$82.25

-0.03 (-0.04%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

BSX

Boston Scientific

$40.41

-0.26 (-0.64%)

PFE

Pfizer

$42.75

0.24 (0.56%)

CRY

CryoLife

$29.13

-0.13 (-0.44%)

EW

Edwards Lifesciences

$184.00

-0.63 (-0.34%)

ELGX

Endologix

$7.61

0.2 (2.70%)

IAC

IAC

$228.41

-2.63 (-1.14%)

HCA

HCA Healthcare

$126.64

-0.76 (-0.60%)

LMAT

LeMaitre

$26.04

-0.44 (-1.66%)

ORGO

Organogenesis

$7.39

0.02 (0.27%)

OSIR

Osiris

$0.00

(0.00%)

PEN

Penumbra

$166.75

2.93 (1.79%)

SWAV

ShockWave Medical

$58.27

-0.99 (-1.67%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 26

    Jun

  • 09

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 16

    Sep

  • 25

    Sep

  • 13

    Nov

CNC

Centene

$53.52

-0.26 (-0.48%)

, WCG

WellCare

$287.16

0.145 (0.05%)

18:45
06/14/19
06/14
18:45
06/14/19
18:45
Hot Stocks
Centene CEO: Medicare for all will not work »

In an interview on…

CNC

Centene

$53.52

-0.26 (-0.48%)

WCG

WellCare

$287.16

0.145 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

HMC

Honda

$25.34

-0.405 (-1.57%)

18:24
06/14/19
06/14
18:24
06/14/19
18:24
Hot Stocks
Honda recalls all 2016-2019 model year Pioneer vehicles »

Honda is conducting a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$111.28

1.42 (1.29%)

18:22
06/14/19
06/14
18:22
06/14/19
18:22
Hot Stocks
RH CEO: We think our stock is massively undervalued »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$37.54

-0.35 (-0.92%)

, S

Sprint

$7.01

0.2 (2.94%)

18:08
06/14/19
06/14
18:08
06/14/19
18:08
Periodicals
Dish leads bidding for Sprint, T-Mobile assets, WSJ reports »

Dish Network (DISH) is…

DISH

Dish

$37.54

-0.35 (-0.92%)

S

Sprint

$7.01

0.2 (2.94%)

TMUS

T-Mobile

$74.90

0.44 (0.59%)

CHTR

Charter

$392.20

2.76 (0.71%)

ATUS

Altice USA

$23.82

0.15 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$32.69

-0.39 (-1.18%)

17:31
06/14/19
06/14
17:31
06/14/19
17:31
Periodicals
American Air asks court to end 'devastating' work slowdown, Bloomberg says »

American Airlines urged a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROLL

RBC Bearings

$150.43

-3.38 (-2.20%)

17:16
06/14/19
06/14
17:16
06/14/19
17:16
Hot Stocks
RBC Bearings CEO sells over 5,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNW

FTE Networks

$1.25

(0.00%)

17:14
06/14/19
06/14
17:14
06/14/19
17:14
Hot Stocks
FTE Networks granted financial viability exception by NYSE regulation »

FTE Networks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$347.19

-1.54 (-0.44%)

17:14
06/14/19
06/14
17:14
06/14/19
17:14
Hot Stocks
Boeing awarded Air Force contract modification, increases ceiling by $6.53B »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

MDR

McDermott

$7.60

-0.12 (-1.55%)

17:11
06/14/19
06/14
17:11
06/14/19
17:11
Hot Stocks
Chatterjee Fund Management reports 5.6% passive stake in McDermott »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.